189 related articles for article (PubMed ID: 34536931)
21. Discovery of novel piperidine-substituted indolylarylsulfones as potent HIV NNRTIs via structure-guided scaffold morphing and fragment rearrangement.
Li X; Gao P; Huang B; Zhou Z; Yu Z; Yuan Z; Liu H; Pannecouque C; Daelemans D; De Clercq E; Zhan P; Liu X
Eur J Med Chem; 2017 Jan; 126():190-201. PubMed ID: 27750153
[TBL] [Abstract][Full Text] [Related]
22. Discovery of piperidine-linked pyridine analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Chen X; Li Y; Ding S; Balzarini J; Pannecouque C; De Clercq E; Liu H; Liu X
ChemMedChem; 2013 Jul; 8(7):1117-26. PubMed ID: 23650275
[TBL] [Abstract][Full Text] [Related]
23. Design, synthesis, and SAR of naphthyl-substituted Diarylpyrimidines as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Liang YH; Feng XQ; Zeng ZS; Chen FE; Balzarini J; Pannecouque C; De Clercq E
ChemMedChem; 2009 Sep; 4(9):1537-45. PubMed ID: 19591191
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization.
Liu Z; Chen W; Zhan P; De Clercq E; Pannecouque C; Liu X
Eur J Med Chem; 2014 Nov; 87():52-62. PubMed ID: 25240095
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and biological evaluation of CHX-DAPYs as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Yan ZH; Wu HQ; Chen WX; Wu Y; Piao HR; He QQ; Chen FE; De Clercq E; Pannecouque C
Bioorg Med Chem; 2014 Jun; 22(12):3220-6. PubMed ID: 24794751
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and biological evaluation of DAPY-DPEs hybrids as non-nucleoside inhibitors of HIV-1 reverse transcriptase.
Wu HQ; Yao J; He QQ; Chen WX; Chen FE; Pannecouque C; De Clercq E; Daelemans D
Bioorg Med Chem; 2015 Feb; 23(3):624-31. PubMed ID: 25537532
[TBL] [Abstract][Full Text] [Related]
27. Improving Druggability of Novel Diarylpyrimidine NNRTIs by a Fragment-Based Replacement Strategy: From Biphenyl-DAPYs to Heteroaromatic-Biphenyl-DAPYs.
Ding L; Pannecouque C; De Clercq E; Zhuang C; Chen FE
J Med Chem; 2021 Jul; 64(14):10297-10311. PubMed ID: 34197708
[TBL] [Abstract][Full Text] [Related]
28. Design, Synthesis, and Anti-HIV Evaluation of Novel Triazine Derivatives Targeting the Entrance Channel of the NNRTI Binding Pocket.
Chen X; Meng Q; Qiu L; Zhan P; Liu H; De Clercq E; Pannecouque C; Liu X
Chem Biol Drug Des; 2015 Jul; 86(1):122-8. PubMed ID: 25358434
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, biological evaluation and molecular modeling of 4,6-diarylpyrimidines and diarylbenzenes as novel non-nucleosides HIV-1 reverse transcriptase inhibitors.
Ribone SR; Leen V; Madrid M; Dehaen W; Daelemans D; Pannecouque C; Briñón MC
Eur J Med Chem; 2012 Dec; 58():485-92. PubMed ID: 23159806
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, anti-HIV evaluation and molecular modeling of piperidine-linked amino-triazine derivatives as potent non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Liu X; Cheng Z; Meng C; Shao S; Pannecouque C; De Clercq E; Liu X
Bioorg Med Chem; 2012 Jun; 20(12):3856-64. PubMed ID: 22591854
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and anti-human immunodeficiency virus activity of substituted ( o,o-difluorophenyl)-linked-pyrimidines as potent non-nucleoside reverse transcriptase inhibitors.
Čechová L; Dejmek M; Baszczyňski O; Šaman D; Gao L; Hu E; Stepan G; Jansa P; Janeba Z; Šimon P
Antivir Chem Chemother; 2019; 27():2040206619826265. PubMed ID: 30788976
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of piperidine-substituted triazine derivatives as HIV-1 non-nucleoside reverse transcriptase inhibitors.
Chen X; Zhan P; Pannecouque C; Balzarini J; De Clercq E; Liu X
Eur J Med Chem; 2012 May; 51():60-6. PubMed ID: 22405288
[TBL] [Abstract][Full Text] [Related]
33. Fused heterocycles bearing bridgehead nitrogen as potent HIV-1 NNRTIs. Part 3: optimization of [1,2,4]triazolo[1,5-a]pyrimidine core via structure-based and physicochemical property-driven approaches.
Huang B; Li C; Chen W; Liu T; Yu M; Fu L; Sun Y; Liu H; De Clercq E; Pannecouque C; Balzarini J; Zhan P; Liu X
Eur J Med Chem; 2015 Mar; 92():754-65. PubMed ID: 25626145
[TBL] [Abstract][Full Text] [Related]
34. In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP.
Kang D; Feng D; Jing L; Sun Y; Wei F; Jiang X; Wu G; De Clercq E; Pannecouque C; Zhan P; Liu X
Eur J Med Chem; 2020 May; 193():112237. PubMed ID: 32200201
[TBL] [Abstract][Full Text] [Related]
35. Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitors.
Xu S; Song S; Sun L; Gao P; Gao S; Ma Y; Kang D; Cheng Y; Zhang X; Cherukupalli S; De Clercq E; Pannecouque C; Liu X; Zhan P
Bioorg Med Chem; 2022 Jan; 53():116531. PubMed ID: 34890994
[TBL] [Abstract][Full Text] [Related]
36. Discovery of novel diarylpyrimidines as potent HIV NNRTIs via a structure-guided core-refining approach.
Li X; Chen W; Tian Y; Liu H; Zhan P; De Clercq E; Pannecouque C; Balzarini J; Liu X
Eur J Med Chem; 2014 Jun; 80():112-21. PubMed ID: 24769349
[TBL] [Abstract][Full Text] [Related]
37. Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus.
Tian Y; Liu Z; Liu J; Huang B; Kang D; Zhang H; De Clercq E; Daelemans D; Pannecouque C; Lee KH; Chen CH; Zhan P; Liu X
Eur J Med Chem; 2018 May; 151():339-350. PubMed ID: 29635166
[TBL] [Abstract][Full Text] [Related]
38. Discovery of piperidin-4-yl-aminopyrimidine derivatives as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
Wan ZY; Yao J; Tao Y; Mao TQ; Wang XL; Lu YP; Wang HF; Yin H; Wu Y; Chen FE; De Clercq E; Daelemans D; Pannecouque C
Eur J Med Chem; 2015 Jun; 97():1-9. PubMed ID: 25935383
[TBL] [Abstract][Full Text] [Related]
39. Development of Novel Dihydrofuro[3,4-
Kang D; Sun Y; Feng D; Gao S; Wang Z; Jing L; Zhang T; Jiang X; Lin H; De Clercq E; Pannecouque C; Zhan P; Liu X
J Med Chem; 2022 Feb; 65(3):2458-2470. PubMed ID: 35061384
[TBL] [Abstract][Full Text] [Related]
40. Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors.
Gu SX; Lu HH; Liu GY; Ju XL; Zhu YY
Eur J Med Chem; 2018 Oct; 158():371-392. PubMed ID: 30223123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
